Swedish regional population-based organised prostate cancer testing: why, what and how?
Objective: This study aimed to describe the regional, population-based, organised prostate cancer testing (OPT) programmes that are being introduced throughout Sweden: motives, structure, target population, diagnostic algorithm, quality control, outcomes, research, and future perspectives. Result...
| Published in: | Scandinavian Journal of Urology |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Medical journals sweden AB
2025-06-01
|
| Subjects: | |
| Online Access: | https://medicaljournalssweden.se/SJU/article/view/43809 |
| _version_ | 1849492189876322304 |
|---|---|
| author | Ola Bratt Salma Tunå Butt Charlotte Carlsson Lisa Jelf-Eneqvist Olof Gunnarsson Alma Ihre Thomas Jiborn Anna Lantz Heide Larsson Helena Strömqvist Johan Styrke Nils-Erik Svedberg Rebecka Arnsrud Godtman |
| author_facet | Ola Bratt Salma Tunå Butt Charlotte Carlsson Lisa Jelf-Eneqvist Olof Gunnarsson Alma Ihre Thomas Jiborn Anna Lantz Heide Larsson Helena Strömqvist Johan Styrke Nils-Erik Svedberg Rebecka Arnsrud Godtman |
| author_sort | Ola Bratt |
| collection | DOAJ |
| container_title | Scandinavian Journal of Urology |
| description |
Objective: This study aimed to describe the regional, population-based, organised prostate cancer testing (OPT) programmes that are being introduced throughout Sweden: motives, structure, target population, diagnostic algorithm, quality control, outcomes, research, and future perspectives.
Results: In 2018, the Swedish National Board of Health and Welfare renewed their recommendation against screening for prostate cancer. Despite this, regional OPT was considered motivated to (1) improve cost-effectiveness compared with unorganised testing, (2) improve equity by giving every man in the target population a chance to make an informed choice, and (3) gain diagnostic and organisational knowledge. The OPT programmes are provided as a regional public healthcare service. They are coordinated by a national working group. The final target population is all men aged 50–74 years. Regional OPT offices use a national administrative system to organise all steps from sending invitation letters to prostate biopsy according to a strict diagnostic algorithm. General practice is involved for blood draw only or not at all. Data are registered in a national register (SweOPT); an annual report is published with the regions’ performance on key indicators. At the end of 2024, 16 of the 21 Swedish regions had started OPT and invited 256,000 men with an average cumulative participation rate of 43%. A consortium co-ordinates OPT-related research. A general experience is that communication and organisational matters have been more challenging than medical decisions.
Conclusions: The Swedish population-based OPT programmes provide organisational experiences, diagnostic outcomes, and research results of value for future national prostate cancer screening programmes.
|
| format | Article |
| id | doaj-art-0131a6dbc35c43bc967e8d537bc9ff13 |
| institution | Directory of Open Access Journals |
| issn | 2168-1813 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Medical journals sweden AB |
| record_format | Article |
| spelling | doaj-art-0131a6dbc35c43bc967e8d537bc9ff132025-08-20T03:07:38ZengMedical journals sweden ABScandinavian Journal of Urology2168-18132025-06-016010.2340/sju.v60.43809Swedish regional population-based organised prostate cancer testing: why, what and how?Ola Bratt0Salma Tunå Butt1Charlotte Carlsson2Lisa Jelf-Eneqvist3Olof Gunnarsson4Alma Ihre5Thomas Jiborn6Anna Lantz7Heide Larsson8Helena Strömqvist9Johan Styrke10Nils-Erik Svedberg11Rebecka Arnsrud Godtman12Department of Urology, Sahlgrenska University Hospital, Göteborg, SwedenDepartment of Surgery, Skåne University Hospital, Lund University, SwedenRegional Cancer Centre South East, Linköping, SwedenRegional Cancer Centre Stockholm-Gotland, Stockholm, SwedenDepartment of Urology, Ryhov County Hospital, Jönköping, SwedenRegional Cancer Centre West, Gothenburg, SwedenDepartment of Urology, Helsingborg Hospital, Helsingborg, SwedenDepartment of Pelvic Cancer, Karolinska University Hospital, Stockholm, SwedenRegional Cancer Centre Mid-Sweden, Uppsala, SwedenRegional Cancer Centre North, Västerbotten County Council, Umeå, SwedenRegional Cancer Centre North, Västerbotten County Council, Umeå, SwedenRegional Cancer Centre Mid-Sweden, Uppsala, SwedenDepartment of Urology, Sahlgrenska University Hospital, Göteborg, Sweden Objective: This study aimed to describe the regional, population-based, organised prostate cancer testing (OPT) programmes that are being introduced throughout Sweden: motives, structure, target population, diagnostic algorithm, quality control, outcomes, research, and future perspectives. Results: In 2018, the Swedish National Board of Health and Welfare renewed their recommendation against screening for prostate cancer. Despite this, regional OPT was considered motivated to (1) improve cost-effectiveness compared with unorganised testing, (2) improve equity by giving every man in the target population a chance to make an informed choice, and (3) gain diagnostic and organisational knowledge. The OPT programmes are provided as a regional public healthcare service. They are coordinated by a national working group. The final target population is all men aged 50–74 years. Regional OPT offices use a national administrative system to organise all steps from sending invitation letters to prostate biopsy according to a strict diagnostic algorithm. General practice is involved for blood draw only or not at all. Data are registered in a national register (SweOPT); an annual report is published with the regions’ performance on key indicators. At the end of 2024, 16 of the 21 Swedish regions had started OPT and invited 256,000 men with an average cumulative participation rate of 43%. A consortium co-ordinates OPT-related research. A general experience is that communication and organisational matters have been more challenging than medical decisions. Conclusions: The Swedish population-based OPT programmes provide organisational experiences, diagnostic outcomes, and research results of value for future national prostate cancer screening programmes. https://medicaljournalssweden.se/SJU/article/view/43809Prostate cancerorganised testingscreeningpopulation-baseddiagnosticsquality control |
| spellingShingle | Ola Bratt Salma Tunå Butt Charlotte Carlsson Lisa Jelf-Eneqvist Olof Gunnarsson Alma Ihre Thomas Jiborn Anna Lantz Heide Larsson Helena Strömqvist Johan Styrke Nils-Erik Svedberg Rebecka Arnsrud Godtman Swedish regional population-based organised prostate cancer testing: why, what and how? Prostate cancer organised testing screening population-based diagnostics quality control |
| title | Swedish regional population-based organised prostate cancer testing: why, what and how? |
| title_full | Swedish regional population-based organised prostate cancer testing: why, what and how? |
| title_fullStr | Swedish regional population-based organised prostate cancer testing: why, what and how? |
| title_full_unstemmed | Swedish regional population-based organised prostate cancer testing: why, what and how? |
| title_short | Swedish regional population-based organised prostate cancer testing: why, what and how? |
| title_sort | swedish regional population based organised prostate cancer testing why what and how |
| topic | Prostate cancer organised testing screening population-based diagnostics quality control |
| url | https://medicaljournalssweden.se/SJU/article/view/43809 |
| work_keys_str_mv | AT olabratt swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow AT salmatunabutt swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow AT charlottecarlsson swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow AT lisajelfeneqvist swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow AT olofgunnarsson swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow AT almaihre swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow AT thomasjiborn swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow AT annalantz swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow AT heidelarsson swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow AT helenastromqvist swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow AT johanstyrke swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow AT nilseriksvedberg swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow AT rebeckaarnsrudgodtman swedishregionalpopulationbasedorganisedprostatecancertestingwhywhatandhow |
